Quarterly UpdatesJul 13, 2026, 04:31 PM
Sanuwave Q2 2026 Revenue Expected $9.6M-$9.8M, Above Guidance
AI Summary
Sanuwave Health, Inc. expects preliminary second quarter 2026 revenues to be between $9.6 million and $9.8 million, exceeding the revised guidance of $8.5 million to $9.5 million. This represents a 3-5% decrease from Q2 2025 revenues of $10.1 million. While capital sales faced headwinds, consumable applicator sales achieved record highs in both unit sales and revenue, indicating a promising trend for future growth.
Key Highlights
- Preliminary Q2 2026 revenue expected to be $9.6M to $9.8M.
- Revenue exceeds revised guidance range of $8.5M to $9.5M.
- Represents a 3-5% decrease from Q2 2025 revenue of $10.1M.
- Consumable applicator sales set all-time records for units and revenue.
- Capital sales faced headwinds from customer stress and used system sales.
- Company offers trade-in program for used Ultramist systems.
Price Impact
More from SNWV